1. Medtech Insight

Attorneys Expect OTC Drug User Fee Deal To Shed Light On Trump-Era Device Regulation

 
• By Elizabeth Orr

Keep an eye on next year’s over-the-counter drug user fee negotiations for insights into the incoming Republican administration's approach to device regulation, attorneys said in a recent webinar. Other areas to watch include AI and diagnostics regulation, with potential bipartisan agreement on AI oversight

Flashlight beam against dark background
(Kryuchka Yaroslav/Shutterstock)

Manufacturers should watch next year’s over-the-counter drug user fee negotiations for an early indication of how the incoming Republican administration may handle device regulation, attorneys with law firm Holland & Knight said during a 4 December webinar.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Medtech Insight

More from Digital Technologies